Comments on: Avastin (Genentech: DNA) Sales - News From the Front http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/ Stocks, Options, Currencies and One Big Dummy Tue, 06 Jan 2009 22:49:18 +0000 http://wordpress.org/?v=2.2.1 By: Genentech, Amgen and More - News from the Front • dummyspots.com http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/#comment-1932 Genentech, Amgen and More - News from the Front • dummyspots.com Fri, 23 Mar 2007 16:34:21 +0000 http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/#comment-1932 [...] I discussed pretty extensively in a post last November the fact that I expected to see sales of Genentech’s Avastin explode in light of the fact that it had been approved for NSCLC at a dose of 15 mg/kg, three times the previously-approved dose of 5 mg/kg for colorectal cancer. [...] […] I discussed pretty extensively in a post last November the fact that I expected to see sales of Genentech’s Avastin explode in light of the fact that it had been approved for NSCLC at a dose of 15 mg/kg, three times the previously-approved dose of 5 mg/kg for colorectal cancer. […]

]]> By: Setup on GOOG; More on StrategyDesk 1.0; Don’t Forget DNA • dummyspots.com http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/#comment-1051 Setup on GOOG; More on StrategyDesk 1.0; Don’t Forget DNA • dummyspots.com Fri, 02 Feb 2007 04:10:44 +0000 http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/#comment-1051 [...] Any other Jungle Book fans out there? Well, either way, an Elephant Never Forgets. Last November I wrote a couple of pleasant little articles on Genentech (ticker: DNA). In the first one, I noted that a break of the 85-86 area could provide an entry for longer-term, um, investors. (If you’re reading ‘em, check out the follow-up post, as well.) [...] […] Any other Jungle Book fans out there? Well, either way, an Elephant Never Forgets. Last November I wrote a couple of pleasant little articles on Genentech (ticker: DNA). In the first one, I noted that a break of the 85-86 area could provide an entry for longer-term, um, investors. (If you’re reading ‘em, check out the follow-up post, as well.) […]

]]> By: lloydphilip http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/#comment-248 lloydphilip Mon, 13 Nov 2006 13:54:49 +0000 http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/#comment-248 Will, All this fundamental analysis is making my head hurt. Tell it to stop. Good info. I will have to add it to my watch and wait to pounce list. Hope you've had a great weekend. LP Will,

All this fundamental analysis is making my head hurt. Tell it to stop.

Good info. I will have to add it to my watch and wait to pounce list. Hope you’ve had a great weekend.

LP

]]> By: john w http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/#comment-245 john w Sun, 12 Nov 2006 14:58:09 +0000 http://dummyspots.com/2006/11/avastin-genentech-dna-sales-news-from-the-front/#comment-245 Let's say you get about 19 points in the next 5 years that takes it from today at 81 to 100. Thats about 20% which parses out to about 4% a year rough averaging - currently you can get 5.25% out of 6 month CDs and can lock in 5% per annum with a 5 year guaranteed. Whenever such you might be inclined to long term speculation always ask yourself what is the risk free rate over the same period sometimes it's the same, sometimes it's more and sometimes it's less. If it is less how much less makes the risk worth taking? You have to answer that question. Good luck. Let’s say you get about 19 points in the next 5 years that takes it from today at 81 to 100. Thats about 20% which parses out to about 4% a year rough averaging - currently you can get 5.25% out of 6 month CDs and can lock in 5% per annum with a 5 year guaranteed.

Whenever such you might be inclined to long term speculation always ask yourself what is the risk free rate over the same period sometimes it’s the same, sometimes it’s more and sometimes it’s less. If it is less how much less makes the risk worth taking? You have to answer that question.

Good luck.

]]>